SciELO - Scientific Electronic Library Online

 
vol.42 número2Metodología de pesquisa preclínica de actividad anti-herpesvirus a partir de productos naturalesResultados reguladores en Cuba con el esquema OMS de certificación de la calidad índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Cubana de Farmacia

versión impresa ISSN 0034-7515versión On-line ISSN 1561-2988

Resumen

VALDIVIA ACOSTA, Alain  y  MARTINEZ SANCHEZ, Gregorio. Foundations of the clinical use of erythropoietin as a neuroprotective agent . Rev Cubana Farm [online]. 2008, vol.42, n.2. ISSN 0034-7515.

The neuroprotective properties of erythropoietin were reported for the first time in preclinical studies approximately a decade ago. The possible mechanism of neuroprotective action of this hormone has not been cleared yet, but here are diverse hypotheses. Erythropoietin has showed good results in preclinic as a neuroprotective agent and there is still a long way to go to attain an adequate effectivity and safety in the clinic in this sense. Research is being carried out to obtain an erythropoietin with neuroprotective activity that lacks or at least has a diminished hematopoietic activity. To reduce its adverse effects, to achieve a significant bioavailability to the central nervous system, to prolong its mean life and to avoid this way a high frequency of administration to the patient, is our main objective. In this paper, it is made a search of the mechanisms of neuroprotective action proposed for erythropoietin so far, and important considerations that may influence on its use in the clinic are stressed.

Palabras clave : Erythropoietin; neuroprotective; clinic; mechanism of action; adverse effects; safety.

        · resumen en Español     · texto en Español

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons